Particularly, dietary flavonoids, potential therapeutic agents in the therapy of liver fibrosis, have been proved to possess the ability to inhibit inflammation by modulating intracellular NF-κB signaling through TLR4 (Geng et al., 2017; Chen et al., 2018a). This evidence concerns the gene NFKB1 and Hepatic fibrosis.